|
2022 Journal Article Factors influencing the initiation of adjuvant endocrine therapy in patients with estrogen receptor-positive ductal carcinoma in situ: a single institution experienceLevy, Julia, Farag, Fady and Cole, John (2022). Factors influencing the initiation of adjuvant endocrine therapy in patients with estrogen receptor-positive ductal carcinoma in situ: a single institution experience. Breast Cancer Research and Treatment, 196 (1), 207-213. doi: 10.1007/s10549-022-06735-9 |
|
2017 Journal Article Endocrine therapy for early breast cancer: Updated reviewTremont, Alexander, Lu, Jonathan and Cole, John T. (2017). Endocrine therapy for early breast cancer: Updated review. Ochsner Journal, 17 (4), 405-411. doi: 10.1043/TOJ-17-0036 |
|
2015 Journal Article Risk assessment and management of anthracycline and HER2 receptor inhibitor-induced cardiomyopathyJahangir, Eiman, Shah, Sangeeta, Shum, Kelly, Baxter, Caitlin, Fitzpatrick, Jill D., Cole, John, Gilliland, Yvonne and Polin, Nichole M. (2015). Risk assessment and management of anthracycline and HER2 receptor inhibitor-induced cardiomyopathy. Southern Medical Journal, 108 (2), 71-78. doi: 10.14423/SMJ.0000000000000232 |
|
2013 Journal Article Cancer stem cell and stromal microenvironmentLi, Li, Cole, John and Margolin, David A. (2013). Cancer stem cell and stromal microenvironment. Ochsner Journal, 13 (1), 109-118. |
|
2012 Journal Article A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potentialLee, Chung-Gi, Das, Bikul, Lin, Tara L., Grimes, Chelsea, Zhang, Xin, Lavezzi, Tracey, Huang, Li, Cole, John, Yau, Lillian and Li, Li (2012). A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential. British Journal of Haematology, 158 (1), 79-90. doi: 10.1111/j.1365-2141.2012.09123.x |
|
2012 Conference Publication L-arginine depletion by PEG-arginase I, a new potential therapy for acute lymphoblastic leukemiaRamos, Ofelia Crombet, Hernandez, Claudia, Morrow, Kevin, Cole, John T. and Rodriguez, Paulo (2012). L-arginine depletion by PEG-arginase I, a new potential therapy for acute lymphoblastic leukemia. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
|
2011 Conference Publication B12 DEFICIENCY REVISITEDJahangir, K. S., Varughese, S., Lin, T. L., Boulmay, B. C., Rigby, P. G. and Cole, J. T. (2011). B12 DEFICIENCY REVISITED. Southern Regional Meeting, New Orleans La, Feb 17-19, 2011. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2011 Conference Publication MY COLLAR BONE HURTS!Varughese, S., Jahangir, K. S., Lin, T., Boulmay, B., Rigby, P. and Cole, J. T. (2011). MY COLLAR BONE HURTS!. Southern Regional Meeting, New Orleans La, Feb 17-19, 2011. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2010 Journal Article Pegylated arginase I: a potential therapeutic approach in T-ALLHernandez, Claudia P., Morrow, Kevin, Lopez-Barcons, Lluis A., Zabaleta, Jovanny, Sierra, Rosa, Velasco, Cruz, Cole, John and Rodriguez, Paulo C. (2010). Pegylated arginase I: a potential therapeutic approach in T-ALL. Blood, 115 (25), 5214-5221. doi: 10.1182/blood-2009-12-258822 |
|
2009 Conference Publication Prelinical Evaluation of Lyn Kinase Inhibition for the Treatment of B Cell Chronic Lymphocytic Leukemia (B-CLL)Velcheti, Vamsidhar, Li, Li, Philips, Joseph, Fuloria, Jyotsna, Rodwig, Francis R., Cole, John T., Samaniego, Felipe and Prakash, Om (2009). Prelinical Evaluation of Lyn Kinase Inhibition for the Treatment of B Cell Chronic Lymphocytic Leukemia (B-CLL). 51st Annual Meeting of the American-Society-of-Hematology, New Orleans La, Dec 05-08, 2009. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2008 Conference Publication Protein Kinase C-Epsilon Is An Important Component of the Lyn Kinase Signaling Pathway in the Apoptotic Resistance of B-Chronic Lymphocytic Leukemia CellsVelcheti, Vamsidhar, Tamma, Srikanth, Larned, Zoe L., Fuloria, Jyotsna, Li, Li, Rodwig, Francis R., Cole, John T., Samaniego, Felipe and Prakash, Om (2008). Protein Kinase C-Epsilon Is An Important Component of the Lyn Kinase Signaling Pathway in the Apoptotic Resistance of B-Chronic Lymphocytic Leukemia Cells. 50th Annual Meeting of the American-Society-of-Hematology, San Francisco Ca, Dec 06-09, 2008. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2008 Conference Publication Differences in treatment and outcomes of non-small cell lung cancer (NSCLC) in Louisiana compared to the rest of the United States: A National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) analysisVelcheti, V., Thumma, V., Matrana, M. and Cole, J. T. (2008). Differences in treatment and outcomes of non-small cell lung cancer (NSCLC) in Louisiana compared to the rest of the United States: A National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) analysis. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2008.26.15_suppl.17507 |
|
2007 Journal Article Chicken Sarcoma to Human Cancers: A Lesson in Molecular TherapeuticsPrakash, Om, Bardot, Stephen F. and Cole, John T. (2007). Chicken Sarcoma to Human Cancers: A Lesson in Molecular Therapeutics. Ochsner Journal, 7 (2), 61-64. |
|
2005 Journal Article A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932Perez, Edith A., Suman, Vera J., Fitch, Tom R., Mailliard, James A., Ingle, James N., Cole, John T., Veeder, Michael H., Flynn, Patrick J., Walsh, Daniel J. and Addo, Ferdinand K. (2005). A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932. Oncology, 69 (2), 117-121. doi: 10.1159/000087813 |
|
2004 Journal Article Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancerLe Chevalier, T., Arriagada, R., Le Pechoux, C., Grunenwald, D., Dunant, A., Pignon, J. P., Tarayre, M., Abratt, R., Arriagada, R., Bergman, B., Gralla, R., Grunenwald, D., Le Chevalier, T., Orlowski, T., Papadakis, E., Pinel, M. I. Sathler, Araujo, C., Della Torre, H., de Solchaga, M. Masetto, Abdi, E., Blum, R., Ball, D., Basser, R., De Boer, R., Bishop, J., Brigham, B., Davis, S., Fox, D., Richardson, G. ... Wedel, H. (2004). Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. New England Journal of Medicine, 350 (4), 351-360. doi: 10.1056/NEJMoa031644 |
|
2001 Journal Article A Phase III study of radiation therapy plus carmustine with or without recombinant interferon-α in the treatment of patients with newly diagnosed high-grade gliomaBuckner, J. C., Schomberg, P. J., McGinnis, W. L., Cascino, T. L., Scheithauer, B. W., O'Fallon, J. R., Morton, R. F., Kuross, S. A., Mailliard, J. A., Hatfield, A. K., Cole, J. T., Steen, P. D. and Bernath, A. M. (2001). A Phase III study of radiation therapy plus carmustine with or without recombinant interferon-α in the treatment of patients with newly diagnosed high-grade glioma. Cancer, 92 (2), 420-433. doi: 10.1002/1097-0142(20010715)92:23.0.CO;2-3 |
|
1995 Journal Article Sepsis due to coryneform group A-4 in an immunocompromised hostBizette, G. A., Kemmerly, S. A., Cole, J. T., Bradford, H. B. and Peltier, B. H. (1995). Sepsis due to coryneform group A-4 in an immunocompromised host. Clinical Infectious Diseases, 21 (5), 1334-1336. doi: 10.1093/clinids/21.5.1334 |
|
1993 Journal Article SPLENECTOMY IN THE HIV-INFECTED PATIENT - REPLYCOLE, JT and FLAUM, MA (1993). SPLENECTOMY IN THE HIV-INFECTED PATIENT - REPLY. Southern Medical Journal, 86 (8), 980-980. doi: 10.1097/00007611-199308000-00032 |
|
1992 Journal Article Postsplenectomy infectionsCole, J. T. and Flaum, M. A. (1992). Postsplenectomy infections. Southern Medical Journal, 85 (12), 1220-1226. doi: 10.1097/00007611-199212000-00014 |
|
1991 Journal Article A Phase I study of a combination of allopurinol, 5-fluorouracil and leucovorin followed by hydroxyurea in patients with advanced gastrointestinal and breast cancerBhalla, K., Birkhofer, M., Bhalla, M., Lutzky, J., Hindenburg, A., Cole, J. and Ince, C. (1991). A Phase I study of a combination of allopurinol, 5-fluorouracil and leucovorin followed by hydroxyurea in patients with advanced gastrointestinal and breast cancer. American Journal of Clinical Oncology - Cancer Clinical Trials, 14 (6), 509-513. doi: 10.1097/00000421-199112000-00009 |
